West Family Investments, Inc. Seagen Inc. Transaction History

West Family Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$191.51 - $216.16 $1,723 - $1,945	9 Added 0.52%	1,750 $371,000
Q2 2023 Aug 15, 2023	BUY	$187.64 - $206.25 $10,507 - $11,550	56 Added 3.32%	1,741 $335,000
Q1 2023 May 03, 2023	BUY	$127.59 - $203.08 $214,989 - $342,189	1,685 New	1,685 $341,000
Q3 2022 Nov 04, 2022	BUY	$135.27 - $180.11 $222,924 - $296,821	1,648 New	1,648 $225,000
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $203,474 - $335,347	-1,870 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $223,670 - $295,179	1,870 New	1,870 $269,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on West Family Investments, Inc. with notifications on news.